Elasty® D – Cross-Linked HA Dermal Filler | Non-Lidocaine | 2 × 1ml *SALE*

Elasty® D – Cross-Linked HA Dermal Filler | 2 × 1ml

Product Overview

Elasty® D is a professional cross-linked Hyaluronic Acid (HA) dermal filler developed for the correction of moderate to deep facial wrinkles, balanced facial volume restoration and contour enhancement.

Formulated with 24mg/ml cross-linked Hyaluronic Acid, Elasty® D features a medium-density monophasic gel designed to provide an effective balance between elasticity, cohesion, lifting capacity and natural tissue integration.

Elasty® D is manufactured using PNET® (Preserved Natural Entanglement Technology), a patented HA-processing technology designed to preserve the natural entanglement of Hyaluronic Acid chains while producing a durable, cohesive and highly elastic injectable gel.

Positioned between softer fillers intended for fine correction and firmer formulations developed for more substantial structural augmentation, Elasty® D provides a versatile option for treatments requiring moderate volume, wrinkle correction and facial contour support.

Potential professional treatment objectives include:

• Moderate to deep wrinkle correction

• Restoration of moderate facial volume

• Facial contour enhancement

• Cheek refinement

• Chin enhancement

• Jawline refinement

• Lower-face rejuvenation

• Lip enhancement where clinically appropriate

Its balanced gel characteristics are designed to provide sufficient support for contour correction while retaining flexibility and natural facial movement.

Elasty® D is intended strictly for use by appropriately qualified medical or aesthetic professionals with suitable training in dermal filler procedures, facial anatomy, vascular anatomy and complication management.

Pack Contents

Each pack contains:

• 2 × 1ml pre-filled syringes of Elasty® D

• Cross-Linked Hyaluronic Acid: 24mg/ml

• Sterile needle(s), as supplied by the manufacturer

• Sterile, sealed professional-use packaging

Volume per Syringe: 1ml

Total Product Volume: 2ml

Always check the individual product packaging, supplied needle specifications, manufacturer labelling and current Instructions for Use before administration.

Product CompositionCross-Linked Hyaluronic Acid – 24mg/ml

Elasty® D contains 24mg/ml highly purified cross-linked Hyaluronic Acid.

The supplied product information describes the HA as non-animal stabilised Hyaluronic Acid developed to provide moderate volume restoration, wrinkle correction and facial contour enhancement.

Cross-linking increases the persistence and mechanical stability of Hyaluronic Acid compared with non-cross-linked HA formulations, allowing the gel to provide physical correction and tissue support following appropriate professional placement.

Within Elasty® D, the cross-linked HA gel is designed to support:

• Moderate volume restoration

• Moderate to deep wrinkle correction

• Facial contour enhancement

• Tissue support

• Natural-looking augmentation

• Smooth tissue integration

The formulation provides greater structural support than a softer fine-line filler while maintaining sufficient flexibility for natural facial movement.

PNET® – Preserved Natural Entanglement Technology

Elasty® D is manufactured using PNET® – Preserved Natural Entanglement Technology.

According to the supplied product information, PNET® is designed to preserve the natural structure and entanglement of Hyaluronic Acid while producing a cohesive, elastic and durable injectable gel.

The technology is designed to provide a balance of:

• High elasticity

• Strong cohesion

• Gel stability

• Durability

• Smooth injectability

• Natural mouldability

• Predictable tissue integration

These characteristics allow Elasty® D to provide support within appropriately selected tissues while accommodating normal facial expression and movement.

Medium-Density Monophasic HA Gel

Elasty® D features a medium-density monophasic Hyaluronic Acid gel.

This balanced gel structure positions Elasty® D between softer formulations intended for delicate correction and firmer fillers designed for more substantial structural augmentation.

The supplied product information describes the formulation as providing:

• Excellent elasticity

• High cohesion

• Effective lifting capacity

• Natural mouldability

• Smooth tissue integration

• Durable aesthetic correction

This balance makes Elasty® D a versatile option for facial treatments requiring greater support than a fine-line filler without necessarily requiring the characteristics of a high-density structural formulation.

Moderate to Deep Wrinkle Correction

Elasty® D is developed for the correction of moderate to deeper facial wrinkles and folds where greater support is required than would typically be provided by a softer filler.

Depending upon individual anatomy and manufacturer-authorised indications, treatment objectives may include:

• Softening moderate facial folds

• Improving deeper wrinkles

• Supporting areas of age-related volume loss

• Restoring smoother facial transitions

• Improving lower-face contours

Product selection should always consider the depth and severity of the wrinkle or fold, tissue thickness, treatment plane and individual patient anatomy.

Facial Volume Restoration

Age-related changes can result in redistribution and loss of facial volume, affecting facial proportions and contours.

Elasty® D is designed to provide balanced volume restoration in appropriately selected areas.

Potential treatment objectives may include:

• Restoring moderate facial volume

• Supporting cheek contours

• Improving chin proportions

• Refining the lower face

• Supporting facial symmetry

• Restoring smoother facial transitions

The objective should be proportionate restoration rather than unnecessary overcorrection.

Facial Contour Enhancement

The medium-density gel characteristics of Elasty® D provide sufficient support for selected facial contouring treatments.

Depending upon patient anatomy and the manufacturer's authorised indications, treatment may be considered where objectives include:

• Cheek contour enhancement

• Chin refinement

• Jawline definition

• Lower-face contouring

• Profile balancing

• Restoration of age-related contour changes

The amount of product and treatment approach should always be individually determined.

Lip Enhancement

The supplied product information also identifies the lips as a potential treatment area.

Where permitted by the current manufacturer Instructions for Use and clinically appropriate, Elasty® D may be considered where a practitioner requires greater support or volume than would typically be achieved using a softer filler.

Potential objectives may include:

• Lip volume enhancement

• Lip contour refinement

• Improved definition

• Correction of selected asymmetry

• Restoration of age-related volume loss

Product choice for lip treatment should always be based on the patient's anatomy, desired outcome, tissue characteristics and the rheological properties of the selected filler.

Key Benefits

• Professional cross-linked HA dermal filler

• 24mg/ml Hyaluronic Acid

• 2 × 1ml pre-filled syringes

• 2ml total product volume

• Manufactured using PNET® technology

• Medium-density monophasic gel

• High elasticity

• Strong cohesion

• Effective lifting capacity

• Designed for smooth tissue integration

• Natural mouldability

• Supports moderate to deep wrinkle correction

• Supports balanced facial volume restoration

• Supports facial contour enhancement

• Suitable for selected cheek treatments

• Suitable for selected chin treatments

• Suitable for selected jawline treatments

• Suitable for lip enhancement where appropriate

• Supports natural-looking facial rejuvenation

• Designed to maintain natural facial movement

• Provides immediate physical correction

• Intended strictly for appropriately qualified professional use

Common Treatment Areas

The supplied product information identifies potential treatment areas including:

• Nasolabial folds

• Marionette lines

• Lips

• Chin

• Cheeks

• Jawline

• Lower face

Treatment suitability must always be determined according to:

• Manufacturer-authorised indications

• Individual facial anatomy

• Vascular anatomy

• Tissue thickness

• Degree of volume loss

• Depth of wrinkles or folds

• Previous aesthetic treatments

• Practitioner competence

• Individual treatment objectives

Always follow the manufacturer's current Instructions for Use regarding authorised indications, treatment depth, administration technique, product volume and placement.

Elasty® F vs Elasty® D

Elasty® F and Elasty® D are designed for different levels of correction.

Elasty® F

The softer formulation is positioned primarily for:

• Fine lines

• Superficial to moderate wrinkles

• Delicate facial correction

• Subtle lip enhancement

• Lip contour refinement

• Softer, more flexible correction

Elasty® D

The medium-density formulation is positioned for:

• Moderate to deep wrinkles

• Greater volume restoration

• Facial contour enhancement

• Cheek refinement

• Chin enhancement

• Jawline refinement

• Lower-face correction

• Lip enhancement where greater support is required

Elasty® D therefore provides a step up in structural support and lifting capacity compared with Elasty® F while retaining flexibility for natural facial movement.

Elasty® D vs Firmer Structural Fillers

Elasty® D provides balanced structural support but should also be differentiated from firmer, higher-density fillers intended for more substantial projection or deep-volume correction.

Elasty® D

Designed to balance:

• Volume

• Flexibility

• Wrinkle correction

• Contouring

• Tissue integration

• Natural movement

Firmer Structural Formulations

These are generally selected where the primary objectives require greater:

• Projection

• Deep structural support

• Lifting capacity

• Contour definition

• Substantial volume restoration

The most appropriate filler should always be selected according to patient anatomy, treatment objective and product characteristics rather than simply choosing the firmest available formulation.

Elasty® D vs Skin Boosters

Elasty® D should not be considered equivalent to a non-cross-linked Hyaluronic Acid skin booster.

Skin Boosters

These products generally focus on:

• Hydration

• Moisture retention

• Skin texture

• Elasticity

• General skin-quality improvement

Elasty® D

As a cross-linked dermal filler, Elasty® D is designed to provide:

• Physical volume

• Wrinkle correction

• Tissue support

• Facial contour enhancement

• Projection where appropriate

• Immediate physical correction

Although Hyaluronic Acid attracts water, Elasty® D should therefore be positioned primarily as a dermal filler rather than a hydrating skin booster.

Recommended Treatment Approach

Elasty® D is generally administered as an individually planned dermal filler treatment following professional assessment.

The supplied information describes a typical approach as:

• Initial Treatment: Single treatment session

• Review: Approximately 2 weeks following treatment where clinically indicated

• Maintenance: Approximately every 9–12 months

These intervals should not be considered a universal protocol or guarantee of product longevity.

Treatment planning should consider:

• Patient anatomy

• Degree of volume loss

• Treatment area

• Tissue characteristics

• Depth of wrinkles or folds

• Previous filler treatments

• Product persistence

• Clinical response

• Individual aesthetic objectives

Further treatment should only be considered following appropriate professional reassessment.

Professional Treatment Considerations

Elasty® D should only be administered by appropriately qualified and trained medical or aesthetic professionals with suitable competence in dermal filler procedures.

Treatment planning should include:

• Comprehensive patient consultation

• Full medical history

• Detailed facial assessment

• Assessment of facial proportions

• Assessment of volume loss

• Evaluation of tissue characteristics

• Evaluation of vascular anatomy

• Review of previous dermal filler treatments

• Assessment of contraindications

• Discussion of realistic treatment expectations

• Explanation of potential adverse effects and complications

• Appropriate documented informed consent

Treatment depth, technique, product volume and distribution should always be determined according to individual anatomy, treatment area, treatment objectives and the manufacturer's current Instructions for Use.

Results & Treatment Outcomes

Elasty® D provides immediate physical correction and volume following appropriate professional placement.

Potential treatment outcomes may include:

• Smoother-looking moderate to deep wrinkles

• Improved facial volume

• Enhanced cheek contours

• Improved chin proportions

• Improved jawline definition

• Improved lower-face contours

• Enhanced lip volume where appropriate

• Improved facial balance

• Natural-looking rejuvenation

Initial swelling following treatment may temporarily influence the appearance of the treated area.

The final aesthetic result becomes clearer as treatment-related swelling settles and the product integrates within the tissue.

Results & Longevity

The supplied product information describes typical clinical longevity of approximately:

9–12 months

This should be considered an approximate range rather than a guaranteed duration.

Individual longevity can vary according to:

• Treatment area

• Product volume

• Treatment technique

• Patient metabolism

• Facial movement

• Tissue characteristics

• Patient age

• Lifestyle

• Individual biological response

More mobile anatomical areas may demonstrate different persistence compared with less mobile areas.

Maintenance treatment may subsequently be considered following professional reassessment.

Natural Facial Movement

An effective facial filler must provide sufficient support while integrating appropriately with the surrounding tissues.

Elasty® D's combination of elasticity and cohesion is designed to support correction while maintaining natural facial expression.

This balance may be particularly useful where the practitioner requires:

• Greater support than a fine-line filler

• Moderate lifting capacity

• Natural mouldability

• Smooth tissue integration

• Natural facial movement

Clinical outcomes remain highly dependent upon correct patient selection, product selection, treatment depth, volume and practitioner technique.

Storage & Handling

Elasty® D should be stored and handled according to the manufacturer's current Instructions for Use and information supplied with the original product.

To maintain product integrity:

• Keep the product within its original packaging until required.

• Follow the manufacturer's specified storage conditions.

• Protect from inappropriate environmental exposure.

• Inspect each syringe and outer packaging before use.

• Check the batch number and expiry date.

• Verify authenticity and traceability.

• Maintain appropriate aseptic handling procedures.

• Do not use if sterile packaging is damaged.

• Do not use if a syringe appears compromised.

• Do not use after the stated expiry date.

Each syringe is intended for single use according to the manufacturer's Instructions for Use.

Important Information

Elasty® D is intended strictly for use by appropriately qualified and trained medical or aesthetic professionals.

Professional knowledge of the following is essential:

• Facial anatomy

• Vascular anatomy

• Dermal filler techniques

• Appropriate treatment planes

• Patient selection

• Aseptic practice

• Complication prevention

• Recognition of vascular compromise

• Emergency management

• Dermal filler complication management

Patient Assessment

Treatment should only proceed following:

• Full patient consultation

• Comprehensive medical history

• Detailed facial assessment

• Examination of the proposed treatment area

• Review of previous aesthetic treatments

• Assessment of contraindications

• Discussion of realistic treatment expectations

• Explanation of potential adverse effects and complications

• Appropriate documented informed consent

Contraindications & Precautions

The supplied information does not provide a complete manufacturer-defined contraindication list.

Practitioners should therefore consult the current Elasty® D Instructions for Use for the complete contraindications, warnings and precautions applicable to the product.

Treatment should not proceed where product sterility, integrity, authenticity or traceability cannot be established.

Potential Treatment Reactions

Temporary effects associated with injectable dermal filler treatment may include:

• Redness

• Swelling

• Bruising

• Tenderness

• Discomfort

• Localised firmness

• Temporary contour irregularity

The precise adverse-event profile should be confirmed from the manufacturer's current Instructions for Use.

Serious Dermal Filler Complications

Injectable dermal filler procedures carry the potential for more significant complications, including infection, inflammatory reactions and vascular complications.

Inadvertent intravascular administration can result in serious tissue injury and, depending upon the anatomical region involved, potentially severe complications.

Appropriate knowledge of vascular anatomy, prevention strategies, early recognition and complication management is therefore essential.

Patients should receive appropriate aftercare information and clear instructions regarding symptoms requiring urgent professional assessment.

Always consult the manufacturer's current Instructions for Use for complete information regarding indications, contraindications, warnings, precautions, administration and potential adverse events.

For appropriately qualified professional use only.